
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker is poised for continued growth in the near term due to its strong position in the reconstructive orthopedic implants and operating room equipment market, as well as its recent acquisitions in the medical technology space. However, there are potential risks to the company's growth, including a potential slowdown in the growth contribution from its flagship products and potential competition from other players in the orthopedic robotics market. The recent cyberattack could also have a negative impact on SYK's first-quarter results, but the company expects to recover lost sales over the remainder of 2026. The international segment has outpaced the US segment, and positive pricing has been sustained overall. While there are some potential risks to our outlook, we believe that Stryker has the potential to sustain above-average revenue and EPS growth, and we view it as one of the best-positioned large-cap med tech companies.
Bears say
Stryker is facing increased competition in its robotic systems from several other companies, as well as uncertainty surrounding slower-than-expected adoption in the ASC setting. Additionally, the company's reliance on acquisitions for growth may pose a risk, and macroeconomic headwinds could further impact sales and earnings. These factors, combined with the stock's already high valuation, lead to a negative outlook on the stock.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares